Australia’s specialist fast track has registered 801 overseas doctors and India remains off the list

As at 31 August 2026, 1,019 internationally qualified specialists had applied for Australian registration through the Medical Board of Australia’s Expedited Specialist pathway, and 801 had been registered through it. The Board’s own monthly summary report breaks those applications down by country of specialist qualification. There were 889 from the United Kingdom, 92 from New Zealand, 37 from Ireland and one from Canada. There is no Indian column in that chart, because no Indian qualification appears anywhere on the Board’s accepted qualification list.

That absence matters. On the slower route, where overseas specialists are assessed one by one by a specialist medical college, India was the single largest source of primary medical degrees in 2025, with 278 applicants, ahead of Pakistan on 212 and Sri Lanka on 168. Indian-trained doctors are not on the edge of this system. They are its largest single national cohort, and they are the cohort the fast track was not built for.

AHPRA specialist registration, what the fast track does and who built it

The Expedited Specialist pathway opened on 21 October 2024 in response to the Independent Review of Australia’s Regulatory Settings Relating to Overseas Health Practitioners, led by Robyn Kruk AO, which called for expedited registration pathways in acknowledged areas of shortage.

The mechanism is narrow. A specialist whose qualification sits on the Board’s published accepted qualification list applies directly to the Board for specialist registration under section 58(b) of the National Law. There is no college comparability assessment, no interview and no summary of preliminary review. Registration is granted with conditions, usually six months of supervised practice, an orientation to the Australian health system, cultural safety education and workplace-based assessments. Once the conditions are met, the Board removes them.

Dr Susan O’Dwyer, a Queensland medical administrator who led the Board’s Specialist IMG taskforce as a Board member, told the Board’s annual meeting in April 2024 that specific qualifications “would be validated and become part of a published list of eligible qualifications”, and that “the Board is pulling out all stops to create a safe and effective policy platform”. She succeeded Dr Anne Tonkin as Board Chair in December 2024 and remained in the role as at August 2026. At the same meeting, Professor Brendan Murphy AC, Australia’s former Chief Medical Officer, said “this is an international marketplace where we must be competitive”.

The accepted qualifications list runs to four countries

The pathway now covers seven specialties: anaesthesia, diagnostic radiology, general medicine, general paediatrics, general practice, obstetrics and gynaecology, and psychiatry. Dermatology, emergency medicine, general surgery and otolaryngology are listed as priority specialties still under consideration.

Every accepted qualification comes from one of four jurisdictions. General practice accepts the MRCGP with a UK Certificate of Completion of Training from August 2007, the MICGP with an Irish Certificate of Satisfactory Completion of Specialist Training from 2009, and Fellowship of the Royal New Zealand College of General Practitioners from 2012. Psychiatry and general medicine accept UK qualifications only. Anaesthesia, obstetrics and gynaecology and general paediatrics accept UK and Irish qualifications. Diagnostic radiology, added on 1 July 2026, accepts only a Canadian certificate.

The list is not a blanket recognition of those countries either. UK general practitioners who trained through the CCT Combined Training Pathway are excluded. When the Australian Medical Council assessed UK and Irish diagnostic radiology qualifications ahead of the July 2026 opening, it could not establish that they were substantially equivalent to the Australian fellowship, and they were not added. India appears zero times on the list.

The uptake figures as at the end of July 2026

Of the 985 applications received since the pathway opened, 840 were for general practice, 68 for psychiatry, 46 for anaesthesia and 24 for obstetrics and gynaecology, with single figures for the three specialties added in 2026. Registrations by country of specialist qualification stood at 664 from the United Kingdom, 67 from New Zealand and 28 from Ireland, with none yet from Canada.

The Board’s first annual report on the pathway, covering 2025, records 526 applications and 465 registrations, with 80 per cent of complete applications finalised within six weeks. By 31 December 2025, 46 specialists had finished the pathway and moved to unconditional registration, most within six to eight months.

Ahpra chief executive Justin Untersteiner addressed the reform in a speech to the Royal Australasian College of Surgeons’ annual scientific congress in Perth on 3 May 2026. He said governments had judged workforce shortages acute enough to justify intervention, that expedited pathways across the professions had seen “more than 2,000 practitioners commence work in Australia”, and that the original announcement “was met with anger by some colleges and practitioners”.

What an Indian-trained doctor has to do instead

For general registration, an Indian medical graduate uses the Standard pathway. That means primary source verification of qualifications, the AMC CAT MCQ examination, then either the AMC clinical examination or a workplace-based assessment, plus 12 months of supervised practice at a minimum of 47 weeks full time equivalent. Those heading into general practice also need a pre-employment structured clinical interview.

The Competent Authority pathway, which lets doctors skip the AMC examinations, recognises six bodies. They are the General Medical Council, the Medical Council of Canada, the Educational Commission for Foreign Medical Graduates and the National Board of Osteopathic Medical Examiners in the United States, the Medical Council of New Zealand and the Medical Council of Ireland. Neither India’s National Medical Commission nor the National Board of Examinations in Medical Sciences is among them.

An Indian-trained specialist uses the Specialist pathway, applying to the relevant college for a comparability assessment. The college rates the applicant substantially comparable, partially comparable or not comparable, then sets three to 24 months of supervised practice and, for partially comparable applicants, examinations.

India is the largest single source of applicants on the slower route

The Medical Board’s 2025 report on college specialist pathway data shows what that looks like in practice. Across all colleges, 196 applicants from India received an interim assessment in 2025. Fourteen per cent were assessed as not comparable, 67 per cent as partially comparable and 19 per cent as substantially comparable. For the 494 applicants from the United Kingdom, three per cent were not comparable, 60 per cent partially comparable and 37 per cent substantially comparable.

The volumes are substantial. There were 3,082 specialist international medical graduates on the Specialist pathway in 2025, up from 2,711 in 2024, with 950 at the RACGP and 557 at the Royal Australasian College of Physicians. RACGP applications fell to 434, which the Board attributes to eligible British, Irish and New Zealand GPs moving to the expedited route, 60 of them switching outright.

Where the colleges have gone further than the Medical Board

Two college decisions are worth knowing about, because they do include India.

The Royal Australasian College of Physicians runs an Accelerated Specialist Pathway that names India explicitly. Applicants must hold both an MD in general medicine or general paediatrics and a DM in the specialty applied for. A Diploma in Child Health from India is not accepted, on the basis that it represents only two years of training. Decisions arrive in roughly six weeks rather than the up to six months quoted for the standard route, and no interview is normally required. Indian applicants found substantially comparable will usually complete 12 months of peer review, against six months for British and Irish applicants. The RACP quotes total fees of $12,082 for a substantially comparable outcome and $16,884 for a partially comparable one.

The RACGP’s curricula classification is the second. Membership of the Royal College of General Practitioners International South Asia sits on its eligible list, reviewed in March 2023. That assessment is delivered in Chennai through the Indian Medical Association, and the RCGP states that its curriculum is “unique to the country it was developed for” and different from the UK MRCGP curriculum.

India’s own Diplomate of National Board for the Practice of Family Medicine and the Christian Medical College postgraduate diploma in family medicine both sit on the RACGP’s not eligible list. An Indian GP with MRCGP[INT] South Asia therefore has a recognised curriculum for RACGP assessment, but no route onto the Board’s expedited list, which requires the UK MRCGP with a UK CCT.

The gap in time and money, measured

The Board published a direct comparison of the two pathways for 2025. Of the 46 specialists who completed the Expedited Specialist pathway that year, 96 per cent did so in under a year from the date of a complete application. On the Specialist pathway, across the same four specialties, only eight per cent finished in under a year. Fifty-five per cent took one to two years, 25 per cent took two to three years, six per cent took three to four years and six per cent took more than four. Registration was granted to 97 per cent of expedited applicants. On the Specialist pathway, 93 per cent of eligible applicants received an interim outcome of partially or substantially comparable, which made them eligible to apply for limited or provisional registration.

The money runs the same way. AMC fees are $642 for an initial portfolio, $2,920 for the CAT MCQ examination, $3,000 for the in-person clinical examination or $3,400 online, and $1,070 for a workplace-based assessment. The RACGP charges $605 for a comparability application and $12,525 for the Practice Experience Program Specialist itself, against $990 for a doctor who completes the expedited pathway and then applies for Fellowship.

Section 19AB of the Health Insurance Act sits on top of it. The ten-year moratorium restricting Medicare access for overseas-trained doctors scales down to nine years in inner regional areas, seven in outer regional, six in remote and five in very remote. It applies whichever pathway a doctor used.

The rural shortfall the fast track has not fixed

Where the fast-tracked specialists have gone is contested. The Board’s 2025 data records 11 per cent of expedited registrants completing supervised practice in Modified Monash 2 to 7 rural and remote locations, with 88 per cent in a distribution priority area or district of workforce shortage. Reporting by Holly Payne in The Medical Republic on 12 June 2026 found that of 368 specialist GPs who applied and began supervised practice during 2025, just 39 did so outside an MM1 location.

RACGP Rural Chair Professor Michael Clements told the publication it was “a bit farcical to call it a distribution priority tool when this is the outcome”. ACRRM President Dr Rod Martin observed that “most of these people have come from the UK” and that “the easiest way to transition to that is to go to larger hospital settings”. Dr Raymond ‘RT’ Lewandowski, immediate past president of the Rural Doctors Association of Australia, said the distribution system is “almost meaningless now, really”.

The colleges opposed the pace of the reform from the outset. Then RACGP president Dr Nicole Higgins said in October 2024 that “Australia’s health ministers and AHPRA have pushed this through regardless of the major risks, unanswered questions, and lack of detail about how a GP’s suitability to practise will be assessed, just a week before it’s due to be implemented”. Health Minister Mark Butler responded that the government “won’t compromise on our very strong standards”.

The RACGP has since built around the pathway rather than against it. In September 2025 it opened a Fellowship option for doctors who complete the expedited route. Dr Ramya Raman, then RACGP Vice President and elected the college’s next president on 24 August 2026 to take office on 19 November, said Fellowship “recognises equivalence” and that “it is not a shortcut and does not reduce RACGP oversight”. Raman was born in Orange, New South Wales, took her medical degree at the University of Notre Dame in Fremantle, directs a Perth practice and heads general practice at Notre Dame’s medical school. Her election gives the college an Indian-origin president, though she is Australian-trained and needed neither pathway.

This article is general information only. It is not migration advice or professional registration advice. Anyone considering registration in Australia should check requirements directly with Ahpra, the Medical Board and the relevant specialist college, as lists and fees change.

The 889 British applicants and the zero Indian ones are not an accident of demand. They are the output of a list, and that list sits inside a system now under review. The Board consulted between 15 June and 27 July 2026 on replacing the college assessment standards with new Specialist pathway requirements. Nothing in that proposal adds a country to the expedited list, and neither does the Board’s own evaluation of the pathway, published in August 2026. For an Indian-trained specialist in 2026, the fast track is shut, the college route is open, and the RACP and the RACGP have gone further on Indian qualifications than the regulator has.